NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NAVCO Pharmaceuticals Inc. has partnered with SOF Marketing on a $300,000 CAD initiative aimed at enhancing investor relations through a comprehensive online marketing strategy. The campaign, running until October 12, 2024, includes rebranding, social media marketing, and targeted AdWords advertising. NAVCO specializes in nanotechnology for developing innovative products to combat various pathogens, serving markets in human health, household products, and veterinary care.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.